Cancer Clinical Trial -AlloVir- P-106-001

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell Transplant

Drug

Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection, Respiratory Syncytial Viral (RSV) Infection, Influenza Infection

Phase

Phase I/II

Condition

Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection, Respiratory Syncytial Viral (RSV) Infection, Influenza Infection

Keywords

ALVR106 | Placebo